174 related articles for article (PubMed ID: 32909482)
21. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.
Kosary CL
Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784
[TBL] [Abstract][Full Text] [Related]
22. Endometrial stromal tumors: an update on a group of tumors with a protean phenotype.
Oliva E; Clement PB; Young RH
Adv Anat Pathol; 2000 Sep; 7(5):257-81. PubMed ID: 10976906
[TBL] [Abstract][Full Text] [Related]
23. Advances in the diagnosis and treatment of uterine sarcomas.
Dizon DS; Birrer MJ
Discov Med; 2014 Jun; 17(96):339-45. PubMed ID: 24979254
[TBL] [Abstract][Full Text] [Related]
24. Uterine sarcomas.
Moinfar F; Azodi M; Tavassoli FA
Pathology; 2007 Feb; 39(1):55-71. PubMed ID: 17365823
[TBL] [Abstract][Full Text] [Related]
25. Prognostic importance of vascular endothelial growth factor and its receptors in the uterine sarcoma.
Arita S; Kikkawa F; Kajiyama H; Shibata K; Kawai M; Mizuno K; Nagasaka T; Ino K; Nomura S
Int J Gynecol Cancer; 2005; 15(2):329-36. PubMed ID: 15823121
[TBL] [Abstract][Full Text] [Related]
26. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
D'Angelo E; Spagnoli LG; Prat J
Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
[TBL] [Abstract][Full Text] [Related]
27. YWHAE-FAM22 endometrial stromal sarcoma: diagnosis by reverse transcription-polymerase chain reaction in formalin-fixed, paraffin-embedded tumor.
Isphording A; Ali RH; Irving J; Goytain A; Nelnyk N; Hoang LN; Gilks CB; Huntsman DG; Nielsen TO; Nucci MR; Lee CH
Hum Pathol; 2013 May; 44(5):837-43. PubMed ID: 23159154
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors associated with uterine sarcomas: the experience of a single institution.
Barquet-Muñoz SA; Isla-Ortiz D; Montalvo-Esquivel G; Cantú-de-León D; Salcedo-Hernández RA; Cordoba-Gonzalez V; Herrera-Gómez Á
J Obstet Gynaecol; 2019 Feb; 39(2):231-236. PubMed ID: 30354797
[TBL] [Abstract][Full Text] [Related]
29. Gynecological sarcomas, surgical management: primary, metastatic, and recurrent disease.
Ferron G; Bataillon G; Martinez A; Chibon F; Valentin T
Int J Gynecol Cancer; 2024 Mar; 34(3):393-402. PubMed ID: 38438176
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic immunohistochemistry in gynaecological neoplasia: a brief survey of the most common scenarios.
Kuhn E; Ayhan A
J Clin Pathol; 2018 Feb; 71(2):98-109. PubMed ID: 29183921
[TBL] [Abstract][Full Text] [Related]
31. Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases.
Schoolmeester JK; Howitt BE; Hirsch MS; Dal Cin P; Quade BJ; Nucci MR
Am J Surg Pathol; 2014 Feb; 38(2):176-88. PubMed ID: 24418852
[TBL] [Abstract][Full Text] [Related]
32. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy.
Clavero JM; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Barrette BA; Larson DR; Pairolero PC
Ann Thorac Surg; 2006 Jun; 81(6):2004-7. PubMed ID: 16731120
[TBL] [Abstract][Full Text] [Related]
33. Advancing women's cancer care. Report from the 37th Annual Meeting of the Society of Gynecologic Oncologists, Palm Springs, Calif., USA, March 22-26, 2006.
Mayer Hope J; Bruchim I; Blank SV; Petignat P
Gynakol Geburtshilfliche Rundsch; 2006; 46(4):214-7. PubMed ID: 17068405
[No Abstract] [Full Text] [Related]
34. Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation.
Yilmaz A; Rush DS; Soslow RA
Am J Surg Pathol; 2002 Sep; 26(9):1142-50. PubMed ID: 12218570
[TBL] [Abstract][Full Text] [Related]
35. Ultrasound Features of Uterine Sarcomas.
Oh J; Park SB; Park HJ; Lee ES
Ultrasound Q; 2019 Dec; 35(4):376-384. PubMed ID: 31094892
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemistry in gynecological pathology.
Deavers MT; Malpica A; Silva EG
Int J Gynecol Cancer; 2003; 13(5):567-79. PubMed ID: 14675338
[TBL] [Abstract][Full Text] [Related]
37. More Than 50 Subtypes of Soft Tissue Sarcoma: Paving the Path for Histology-Driven Treatments.
Katz D; Palmerini E; Pollack SM
Am Soc Clin Oncol Educ Book; 2018 May; 38():925-938. PubMed ID: 30231352
[TBL] [Abstract][Full Text] [Related]
38. Treatment of patients with sarcoma of the uterus.
Bokhman JV; Yakovleva IA; Urmanchejeva AF
Eur J Gynaecol Oncol; 1990; 11(3):225-31. PubMed ID: 2209643
[TBL] [Abstract][Full Text] [Related]
39. BCOR Overexpression Is a Highly Sensitive Marker in Round Cell Sarcomas With BCOR Genetic Abnormalities.
Kao YC; Sung YS; Zhang L; Jungbluth AA; Huang SC; Argani P; Agaram NP; Zin A; Alaggio R; Antonescu CR
Am J Surg Pathol; 2016 Dec; 40(12):1670-1678. PubMed ID: 27428733
[TBL] [Abstract][Full Text] [Related]
40. Vulvar sarcomas: Short guideline for histopathological recognition and clinical management. Part 2.
Chokoeva AA; Tchernev G; Cardoso JC; Patterson JW; Dechev I; Valkanov S; Zanardelli M; Lotti T; Wollina U
Int J Immunopathol Pharmacol; 2015 Jun; 28(2):178-86. PubMed ID: 25816393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
